Conexeu Sciences, a preclinical-stage regenerative tissue platform company, has opened a research and development facility in Vancouver. The Nevada-born innovator, which trades on the Nasdaq as CNXU, is opening the R&D facility within adMare BioInnovations’ M4 Innovation Centre. AdMare BioInnovations—which utilizes commercial expertise, specialized R&D infrastructure, and seed capital to support life sciences companies and […]